Small-Sized mPEG–PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity-Reference-Cited by-同舟云学术

Small-Sized mPEG–PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity

Published:2017-03-09 Issue:11 Volume:9 Page:9516-9527
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Chen Tongkai¹,Li Chuwen¹,Li Ye¹,Yi Xiang²,Wang Ruibing¹^ORCID,Lee Simon Ming-Yuen¹,Zheng Ying¹^ORCID

Affiliation:

1. State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China

2. Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27516, United States

Funder

Fundo para o Desenvolvimento das Ci?ncias e da Tecnologia

Fundo de Investiga??o, Universidade de Macau

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.7b01171

Reference47 articles.

1. World Health Organization. Neurological Disorders: Public Health Challenges;WHO Press:Geneva, Switzerland, 2006; pp140–148.

2. Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases

3. Angiopep-Conjugated Nanoparticles for Targeted Long-Term Gene Therapy of Parkinson’s Disease

4. L-Dopa Prodrugs: An Overview of Trends for Improving Parkinsons Disease Treatment

5. The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. To see or not to see: In vivo nanocarrier detection methods in the brain and their challenges;Journal of Controlled Release;2024-07

2. Oral targeted drug delivery to post-gastrointestinal sites;Journal of Controlled Release;2024-06

3. Recent developments in the use of nanocrystals to improve bioavailability of APIs;WIREs Nanomedicine and Nanobiotechnology;2024-03

4. Progress in the Treatment of Central Nervous System Diseases Based on Nanosized Traditional Chinese Medicine;Advanced Science;2024-02-28

5. Polymeric nanotherapeutics: An emerging therapeutic approach for the management of neurodegenerative disorders;Journal of Drug Delivery Science and Technology;2024-01